Want to see HK:3933 full AI Analyst Report?
The United Laboratories International Holdings (3933) Ratios
The United Laboratories International Holdings Ratios
HK:3933's free cash flow for Q2 2026 was $-383.39M. For the 2026 fiscal year, HK:3933's free cash flow was decreased by $-447.07M and operating cash flow was $63.68M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.83 | 1.83 | 2.08 | 1.78 | 1.53 |
| Quick Ratio | 1.60 | 1.55 | 1.74 | 1.47 | 1.22 |
| Cash Ratio | 1.11 | 0.72 | 0.64 | 0.67 | 0.51 |
| Solvency Ratio | 0.21 | 0.28 | 0.40 | 0.25 | 0.23 |
| Operating Cash Flow Ratio | 0.37 | 0.36 | 0.37 | 0.29 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 1.78 | 3.85 | 12.33 | 1.49 | 0.96 |
| Net Current Asset Value | $ 5.14B | $ 4.67B | $ 5.52B | $ 4.14B | $ 3.00B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.12 | 0.07 | 0.13 | 0.11 |
| Debt-to-Equity Ratio | 0.29 | 0.22 | 0.12 | 0.23 | 0.20 |
| Debt-to-Capital Ratio | 0.22 | 0.18 | 0.11 | 0.19 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.14 | 0.09 | 0.09 | 0.02 |
| Financial Leverage Ratio | 1.78 | 1.80 | 1.65 | 1.79 | 1.75 |
| Debt Service Coverage Ratio | 1.11 | 3.14 | 12.59 | 1.47 | 1.06 |
| Interest Coverage Ratio | 32.58 | 89.14 | 49.17 | 24.70 | 23.43 |
| Debt to Market Cap | 0.25 | 0.15 | 0.13 | 0.31 | 0.28 |
| Interest Debt Per Share | 2.69 | 1.76 | 0.86 | 1.40 | 1.03 |
| Net Debt to EBITDA | -2.18 | -0.95 | -0.69 | -0.90 | -0.75 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.74% | 44.21% | 46.11% | 43.84% | 43.40% |
| EBIT Margin | 16.82% | 20.45% | 24.83% | 17.78% | 14.24% |
| EBITDA Margin | 21.73% | 24.36% | 28.94% | 22.40% | 20.38% |
| Operating Profit Margin | 17.20% | 22.65% | 23.94% | 17.78% | 14.55% |
| Pretax Profit Margin | 19.14% | 23.90% | 24.34% | 17.71% | 12.39% |
| Net Profit Margin | 15.79% | 19.33% | 19.66% | 13.95% | 10.18% |
| Continuous Operations Profit Margin | 15.75% | 19.32% | 19.66% | 13.95% | 10.20% |
| Net Income Per EBT | 82.51% | 80.87% | 80.78% | 78.79% | 82.16% |
| EBT Per EBIT | 111.28% | 105.54% | 101.67% | 99.59% | 85.21% |
| Return on Assets (ROA) | 6.75% | 10.30% | 12.85% | 8.33% | 6.05% |
| Return on Equity (ROE) | 11.99% | 18.49% | 21.21% | 14.90% | 10.58% |
| Return on Capital Employed (ROCE) | 10.91% | 18.27% | 22.86% | 16.87% | 14.41% |
| Return on Invested Capital (ROIC) | 8.15% | 14.07% | 18.21% | 12.17% | 10.42% |
| Return on Tangible Assets | 6.81% | 10.38% | 12.86% | 8.33% | 6.05% |
| Earnings Yield | 10.63% | 12.61% | 22.82% | 20.08% | 15.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.88 | 2.28 | 2.34 | 2.53 | 2.83 |
| Payables Turnover | 2.00 | 1.84 | 1.75 | 1.79 | 1.71 |
| Inventory Turnover | 3.25 | 3.15 | 3.31 | 2.94 | 2.74 |
| Fixed Asset Turnover | 1.09 | 1.50 | 2.00 | 1.83 | 1.60 |
| Asset Turnover | 0.43 | 0.53 | 0.65 | 0.60 | 0.59 |
| Working Capital Turnover Ratio | 1.68 | 1.90 | 2.17 | 2.54 | 2.85 |
| Cash Conversion Cycle | 57.13 | 77.36 | 58.07 | 64.15 | 48.59 |
| Days of Sales Outstanding | 126.90 | 160.13 | 155.74 | 144.14 | 128.78 |
| Days of Inventory Outstanding | 112.40 | 115.74 | 110.34 | 124.07 | 133.18 |
| Days of Payables Outstanding | 182.17 | 198.51 | 208.01 | 204.05 | 213.37 |
| Operating Cycle | 239.30 | 275.87 | 266.08 | 268.20 | 261.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.99 | 1.76 | 1.34 | 1.12 | 0.84 |
| Free Cash Flow Per Share | 0.45 | 0.73 | 0.54 | 0.69 | 0.58 |
| Dividend Paid and CapEx Coverage Ratio | 0.95 | 1.11 | 1.19 | 1.93 | 2.19 |
| Capital Expenditure Coverage Ratio | 1.30 | 1.71 | 1.67 | 2.60 | 3.20 |
| Operating Cash Flow Coverage Ratio | 0.75 | 1.01 | 1.62 | 0.82 | 0.84 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.23 | 0.18 | 0.18 | 0.16 |
| Free Cash Flow Yield | 4.36% | 6.30% | 8.26% | 15.89% | 16.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.38 | 7.93 | 4.38 | 4.98 | 6.61 |
| Price-to-Sales (P/S) Ratio | 1.49 | 1.53 | 0.86 | 0.69 | 0.67 |
| Price-to-Book (P/B) Ratio | 1.13 | 1.47 | 0.93 | 0.74 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.94 | 15.87 | 12.11 | 6.29 | 6.16 |
| Price-to-Operating Cash Flow Ratio | 5.23 | 6.59 | 4.85 | 3.88 | 4.24 |
| Price-to-Earnings Growth (PEG) Ratio | -0.39 | -3.94 | 0.06 | 0.08 | 0.19 |
| Enterprise Value Multiple | 4.66 | 5.35 | 2.28 | 2.20 | 2.55 |
| Enterprise Value | 13.38B | 17.92B | 9.08B | 5.59B | 5.04B |
| EV to EBITDA | 4.66 | 5.35 | 2.28 | 2.20 | 2.55 |
| EV to Sales | 1.01 | 1.30 | 0.66 | 0.49 | 0.52 |
| EV to Free Cash Flow | 15.64 | 13.48 | 9.29 | 4.47 | 4.76 |
| EV to Operating Cash Flow | 3.57 | 5.60 | 3.72 | 2.75 | 3.27 |
| Tangible Book Value Per Share | 9.17 | 7.83 | 7.01 | 5.83 | 5.07 |
| Shareholders’ Equity Per Share | 9.23 | 7.92 | 7.01 | 5.83 | 5.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.19 | 0.19 | 0.21 | 0.18 |
| Revenue Per Share | 7.01 | 7.57 | 7.56 | 6.23 | 5.27 |
| Net Income Per Share | 1.11 | 1.46 | 1.49 | 0.87 | 0.54 |
| Tax Burden | 0.83 | 0.81 | 0.81 | 0.79 | 0.82 |
| Interest Burden | 1.14 | 1.17 | 0.98 | 1.00 | 0.87 |
| Research & Development to Revenue | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 |
| SG&A to Revenue | 0.17 | 0.17 | 0.06 | 0.06 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.48 | 0.97 | 0.73 | 1.28 | 1.56 |
Currency in CNY